DK0396188T3 - Antistoffer mod fibrin, immunogene peptider til fremstilling af disse antistoffer, fremgangsmåde til bestemmelse af fibrin og farmaceutiske præparater baseret på disse antistoffer - Google Patents
Antistoffer mod fibrin, immunogene peptider til fremstilling af disse antistoffer, fremgangsmåde til bestemmelse af fibrin og farmaceutiske præparater baseret på disse antistofferInfo
- Publication number
- DK0396188T3 DK0396188T3 DK90201065.1T DK90201065T DK0396188T3 DK 0396188 T3 DK0396188 T3 DK 0396188T3 DK 90201065 T DK90201065 T DK 90201065T DK 0396188 T3 DK0396188 T3 DK 0396188T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibodies
- fibrin
- produce
- pharmaceutical preparations
- immunogenic peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8901102A NL8901102A (nl) | 1989-05-01 | 1989-05-01 | Antilichamen tegen fibrine; voor de bereiding van de antilichamen geschikte immunogene peptiden, werkwijze voor het bepalen van fibrine en farmaceutisch preparaat op basis van de antilichamen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0396188T3 true DK0396188T3 (da) | 1994-08-22 |
Family
ID=19854590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90201065.1T DK0396188T3 (da) | 1989-05-01 | 1990-04-26 | Antistoffer mod fibrin, immunogene peptider til fremstilling af disse antistoffer, fremgangsmåde til bestemmelse af fibrin og farmaceutiske præparater baseret på disse antistoffer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5124439A (da) |
| EP (1) | EP0396188B1 (da) |
| JP (1) | JP2634683B2 (da) |
| AT (1) | ATE108833T1 (da) |
| DE (1) | DE69010750T2 (da) |
| DK (1) | DK0396188T3 (da) |
| ES (1) | ES2060927T3 (da) |
| NL (1) | NL8901102A (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994009034A1 (en) * | 1992-10-12 | 1994-04-28 | Agen Limited | Clot directed anticoagulant, process for making same and methods of use |
| DE69435072T2 (de) * | 1993-11-02 | 2009-01-29 | Mitsubishi Kagaku Iatron, Inc. | Antikörper gegen menschliches lösliches fibrin, hybridome, die sie produzieren und immunmessverfahren |
| CA2188647A1 (en) * | 1994-05-02 | 1995-11-09 | Stewart Anthony Cederholm-Williams | Recombinant fibrin chains, fibrin and fibrin-homologs |
| DE19729591A1 (de) * | 1997-07-10 | 1999-02-11 | Therasorb Medizinische Systeme | Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen |
| US9814672B2 (en) | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
| DE3701812A1 (de) * | 1987-01-22 | 1988-08-04 | Max Planck Gesellschaft | Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung |
-
1989
- 1989-05-01 NL NL8901102A patent/NL8901102A/nl not_active Application Discontinuation
-
1990
- 1990-04-26 ES ES90201065T patent/ES2060927T3/es not_active Expired - Lifetime
- 1990-04-26 DK DK90201065.1T patent/DK0396188T3/da active
- 1990-04-26 EP EP90201065A patent/EP0396188B1/en not_active Expired - Lifetime
- 1990-04-26 AT AT90201065T patent/ATE108833T1/de not_active IP Right Cessation
- 1990-04-26 DE DE69010750T patent/DE69010750T2/de not_active Expired - Fee Related
- 1990-04-30 US US07/516,428 patent/US5124439A/en not_active Expired - Lifetime
- 1990-05-01 JP JP2115711A patent/JP2634683B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69010750T2 (de) | 1994-12-22 |
| DE69010750D1 (de) | 1994-08-25 |
| JPH0348159A (ja) | 1991-03-01 |
| ES2060927T3 (es) | 1994-12-01 |
| EP0396188B1 (en) | 1994-07-20 |
| US5124439A (en) | 1992-06-23 |
| JP2634683B2 (ja) | 1997-07-30 |
| ATE108833T1 (de) | 1994-08-15 |
| EP0396188A1 (en) | 1990-11-07 |
| NL8901102A (nl) | 1990-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK532284D0 (da) | Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser | |
| DK150992A (da) | Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor | |
| DK1137941T3 (da) | Protein-scaffolds til antistof-mimetika og andre bindingsproteiner | |
| DK166087A (da) | Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus | |
| DK0574402T3 (da) | Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf | |
| DK0754704T3 (da) | Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus | |
| DK0532587T3 (da) | Fremgangsmåder til trans-destabilisering af specifikke proteiner in vivo | |
| FI880017A (fi) | Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu | |
| DK166546C (da) | Fremgangsmaade til spaltning af peptider og proteiner ved methionyl-bindingen | |
| DK0658168T3 (da) | Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| DK0901526T3 (da) | Cortistatin: neuropeptider, sammensætninger og metoder | |
| DK0396188T3 (da) | Antistoffer mod fibrin, immunogene peptider til fremstilling af disse antistoffer, fremgangsmåde til bestemmelse af fibrin og farmaceutiske præparater baseret på disse antistoffer | |
| DK406184D0 (da) | Fremgangsmaade til pasteurisering af humanplasma | |
| DK1105508T3 (da) | Fremgangsmåde til oprensning af biomolekyle- eller proteinkomplekser | |
| ATE50458T1 (de) | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern. | |
| DK213589D0 (da) | Antistoffer mod fibrin og immunogen til brug ved fremstilling deraf | |
| PT816377E (pt) | Peptideos que se ligam a protrombina e a trombina | |
| ATE374246T1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
| ATE166231T1 (de) | Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen | |
| DK0994187T3 (da) | Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet | |
| DE59310073D1 (de) | Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen | |
| ES2033295T3 (es) | Un metodo para preparar un activador de plasminogeno. | |
| DK0420043T4 (da) | Antistoffer mod højkonserverede aminosyresekvenser af immunogene stoffer, fremgangsmåde til fremstilling af disse antistoff | |
| ATE84318T1 (de) | Monoklonale antikoerper, spezifisch von in vivo von fibrinogen abgeleiteten derivatstuecken. |